AS
WST icon

Altshuler Shaham’s West Pharmaceutical WST Stock Holding History

Altshuler Shaham’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-57
Closed -$21.4K – 321
2023
Q3 		$21.4K Sell
57
-24
-30% -$9.28K ﹤0.01% 241
2023
Q2 		$31K Buy
+81
New +$28.9K ﹤0.01% 224
2022
Q2 		– Sell
-103
Closed -$42K – 570
2022
Q1 		$42K Sell
103
-185
-64% -$72.4K ﹤0.01% 394
2021
Q4 		$135K Sell
288
-530
-65% -$228K ﹤0.01% 302
2021
Q3 		$349K Buy
818
+694
+560% +$293K ﹤0.01% 211
2021
Q2 		$45K Buy
+124
New +$41K ﹤0.01% 453
2021
Q1 		– Sell
-359
Closed -$102K – 541
2020
Q4 		$102K Sell
359
-1,863
-84% -$523K ﹤0.01% 200
2020
Q3 		$611K Buy
2,222
+55
+3% +$14.6K 0.01% 102
2020
Q2 		$492K Buy
2,167
+1,919
+774% +$377K 0.01% 101
2020
Q1 		$38K Buy
248
+37
+18% +$5.7K ﹤0.01% 199
2019
Q4 		$32K Sell
211
-22
-9% -$3.2K ﹤0.01% 214
2019
Q3 		$33K Buy
233
+145
+165% +$20K ﹤0.01% 197
2019
Q2 		$11K Buy
+88
New +$10.4K ﹤0.01% 289

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Altshuler Shaham's WST Position: Q4 2023 in Review

Altshuler Shaham sold out of West Pharmaceutical (WST) in Q4 2023, closing a stake of 57 shares — an estimated $21.4K sold.

Altshuler Shaham first reported a position in WST in Q2 2019 and held it in 13 quarters. The position peaked at $611K in Q3 2020. 783 funds tracked by Wall St. Rank hold WST as of Q4 2023.

  • Altshuler Shaham reported no remaining West Pharmaceutical position as of Q4 2023 after selling out during the quarter.
  • Altshuler Shaham sold 57 West Pharmaceutical shares in Q4 2023, an estimated $21.4K.
  • Altshuler Shaham first reported a position in West Pharmaceutical in Q2 2019 and held it in 13 quarters.
  • Altshuler Shaham's West Pharmaceutical position peaked at $611K in Q3 2020.
  • 783 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2023.

Based on Altshuler Shaham's 13F filing for Q4 2023, filed 7 Feb 2024.